Cargando…

The standard versus prolonged dual antiplatelet therapy after the XINSORB bioresorbable scaffold implantation (SPARTA) trial: study protocol for a randomized controlled trial

BACKGROUND: Dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 inhibitor is the standard of care after coronary stenting, including coronary stenting involving bioresorbable scaffolds (BRSs). Current clinical guidelines recommend at least 12 months of DAPT after BRS implantation. However, the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Yizhe, Yin, Jiasheng, Li, Chenguang, Zhang, Wei, Shen, Li, Ge, Lei, Qian, Juying, Ge, Junbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854195/ https://www.ncbi.nlm.nih.gov/pubmed/36670441 http://dx.doi.org/10.1186/s13063-022-07028-8

Ejemplares similares

Three-year clinical outcomes of a sirolimus-eluting bioresorbable scaffold (XINSORB) and a metallic stent to treat coronary artery stenosis
por: Wu, Yizhe, et al.
Publicado: (2020)

Final report of the 5-year clinical outcomes of the XINSORB bioresorbable sirolimus-eluting scaffold in the treatment of single de novo coronary lesions in a first-in-human study
por: Wu, Yizhe, et al.
Publicado: (2020)

First-in-man Implantation of the XINSORB Bioresorbable Sirolimus-eluting Scaffold in China
por: Chen, Jia-Hui, et al.
Publicado: (2015)

Comparison of Acute Recoil between Bioabsorbable Poly-L-lactic Acid XINSORB Stent and Metallic Stent in Porcine Model
por: Wu, Yizhe, et al.
Publicado: (2012)

Very late bioresorbable scaffold thrombosis after discontinuation of dual antiplatelet therapy
por: Karanasos, Antonios, et al.
Publicado: (2014)

Prospective multicentre open-label randomised controlled trial of 3-month versus 12-month dual antiplatelet therapy after implantation of the new generation biodegradable polymer sirolimus TARGET-eluting coronary stent: protocol of the TARGET DAPT trial
por: Yang, Hongbo, et al.
Publicado: (2019)

Computed Tomography-Derived Fractional Flow Reserve in the Detection of Lesion-Specific Ischemia: An Integrated Analysis of 3 Pivotal Trials
por: Xu, Rende, et al.
Publicado: (2015)

Bioresorbable Scaffolds: Current Evidence and Ongoing Clinical Trials
por: Bourantas, Christos V., et al.
Publicado: (2012)

From Athens to Sparta—37 Years of Spartathlon
por: Knechtle, Beat, et al.
Publicado: (2021)

Bioresorbable scaffolds: everything resolved?
por: Appelman, Yolande
Publicado: (2015)

Impact of the Xinsorb Scaffold-Related Parameters on Platelet Reactivity in Patients with Single De Novo Coronary Artery Lesions Undergoing Clopidogrel Treatment
por: Yu, Shushu, et al.
Publicado: (2023)

Bioresorbable Scaffolds for Atheroregression: Understanding of Transient Scaffolding
por: N. Kharlamov, M.D., Alexander
Publicado: (2016)

In vivo degradation and endothelialization of an iron bioresorbable scaffold
por: Lin, Wenjiao, et al.
Publicado: (2020)

Excerpts from the Case-Book of T. S. Powell, M. D., Sparta, Georgia
Publicado: (1857)

PARIS and SPARTA: Finding the Achilles’ Heel of SARS-CoV-2
por: Simon, Viviana, et al.
Publicado: (2022)

Bioresorbable scaffolds for percutaneous coronary interventions
por: Gogas, Bill D.
Publicado: (2014)

Bioresorbable Polymeric Scaffold in Cardiovascular Applications
por: Toong, Daniel Wee Yee, et al.
Publicado: (2020)

Scaffold underexpansion and late lumen loss after bioresorbable scaffold implantation: Insights from ABSORB JAPAN trial
por: Okada, Kozo, et al.
Publicado: (2020)

One‐Month Dual Antiplatelet Therapy After Bioresorbable Polymer Everolimus‐Eluting Stents in High Bleeding Risk Patients
por: Pivato, Carlo A., et al.
Publicado: (2022)

Report from the Case-Book of Thos. S. Powell, M. D. Sparta, Georgia
Publicado: (1857)

Bioresorbable scaffolds in the treatment of coronary artery disease
por: Zhang, Yaojun, et al.
Publicado: (2013)

Vascular restoration therapy and bioresorbable vascular scaffold
por: Wang, Yunbing, et al.
Publicado: (2014)

Bioresorbable vascular scaffolds: between promises and reality
por: Montone, Rocco A., et al.
Publicado: (2017)

Bioresorbable Scaffolds: Current Technology and Future Perspectives
por: Forrestal, Brian, et al.
Publicado: (2020)

Bioresorbable Scaffolds: Contemporary Status and Future Directions
por: Peng, Xiang, et al.
Publicado: (2020)

Thrombosis and myocardial infarction: the role of bioresorbable scaffolds
por: Leesar, Massoud A., et al.
Publicado: (2023)

Bioresorbable vascular scaffold versus metallic stent in percutaneous coronary intervention: results of the AIDA trial
por: Shah, Syed Raza, et al.
Publicado: (2017)

Correction to: One‐Month Dual Antiplatelet Therapy After Bioresorbable Polymer Everolimus‐Eluting Stents in High Bleeding Risk Patients
Publicado: (2022)

Parity and Cardiovascular Disease Mortality: a Dose-Response Meta-Analysis of Cohort Studies
por: Lv, Haichen, et al.
Publicado: (2015)

Optimal strategy of primary percutaneous coronary intervention for acute myocardial infarction due to unprotected left main coronary artery occlusion (OPTIMAL): study protocol for a randomised controlled trial
por: Gao, Yang, et al.
Publicado: (2019)

Fully bioresorption of an Absorb bioresorbable vascular scaffold after scaffold restenosis
por: Goncalves-Ramírez, Luis R., et al.
Publicado: (2019)

SPARTA: Simple Program for Automated reference-based bacterial RNA-seq Transcriptome Analysis
por: Johnson, Benjamin K., et al.
Publicado: (2016)

The endothelium permeability after bioresorbable scaffolds implantation caused by the heterogeneous expression of tight junction proteins
por: Huang, Junyang, et al.
Publicado: (2022)

Bioresorbable vascular scaffold: promises and the fallen child-as-king?
por: Cook, Stephane, et al.
Publicado: (2016)

Bioresorbable Vascular Scaffold Korean Expert Panel Report
por: Ahn, Jung-Min, et al.
Publicado: (2017)

Bioresorbable Scaffolds in Coronary Intervention: Unmet Needs and Evolution
por: Capodanno, Davide
Publicado: (2017)

Very-long-term efficacy of bioresorbable vascular scaffolds
por: Shah, R.
Publicado: (2017)

In vitro and in vivo degradation of microfiber bioresorbable coronary scaffold
por: Huang, Chi‐Hung, et al.
Publicado: (2017)

Neoatherosclerosis　― Long-Term Assessment of Bioresorbable Vascular Scaffold ―
por: Moriyama, Noriaki, et al.
Publicado: (2019)

Prolonged dual antiplatelet therapy in stable coronary disease: comparative observational study of benefits and harms in unselected versus trial populations
por: Timmis, A, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_dcr9c67rhn5clq30u7tqhq0rra